Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study
Iida, M. A.; Farrell, K.; Walker, J. M.; Richardson, T. E.; Marx, G.; Bryce, C. H.; Purohit, D.; Ayalon, G.; Beach, T. G.; Bigio, E. H.; Cortes, E.; Gearing, M.; Haroutunian, V.; McMillan, C. T.; Lee, E. B.; Dickson, D.; McKee, A. C.; Stein, T. D.; Trojanowski, J. Q.; Woltjer, R. L.; Kovacs, G. G.; Kofler, J. K.; Kaye, J.; White, C. L.; Crary, J. F.
Show abstract
Primary age-related tauopathy (PART) is a form of Alzheimer-type neurofibrillary degeneration occurring in the absence of amyloid-beta (A{beta}) plaques. While PART shares some features with Alzheimer disease (AD), such as progressive accumulation of neurofibrillary tangle pathology in the medial temporal lobe and other brain regions, it does not progress extensively to neocortical regions. Given this restricted pathoanatomical pattern and variable symptomatology, there is a need to reexamine and improve upon how PART is neuropathologically assessed and staged. We performed a retrospective autopsy study in a collection (n=174) of post-mortem PART brains and used logistic regression to determine the extent to which a set of clinical and neuropathological features predict cognitive impairment. We compared Braak staging, which focuses on hierarchical neuroanatomical progression of AD tau and A{beta} pathology, with quantitative assessments of neurofibrillary burden using computer-derived positive pixel counts on digitized whole slide images of sections stained immunohistochemically with antibodies targeting abnormal hyperphosphorylated tau (p-tau) in the entorhinal region and hippocampus. We also assessed other factors affecting cognition, including aging-related tau astrogliopathy (ARTAG) and atrophy. We found no association between Braak stage and cognitive impairment when controlling for age (p=0.76). In contrast, p-tau burden was significantly correlated with cognitive impairment even when adjusting for age (p=0.03). The strongest correlate of cognitive impairment was cerebrovascular disease, a well-known risk factor (p<0.0001), but other features including ARTAG (p=0.03) and hippocampal atrophy (p=0.04) were also associated. In contrast, sex, APOE, psychiatric illness, education, argyrophilic grains, and incidental Lewy bodies were not. These findings support the hypothesis that comorbid pathologies contribute to cognitive impairment in subjects with PART. Quantitative approaches beyond Braak staging are critical for advancing our understanding of the extent to which age-related tauopathy changes impact cognitive function.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- APOE-ε 4 and BIN1 increase risk of Alzheimer’s disease pathology but not specifically of Lewy body pathology 96%
- Protein farnesylation is upregulated in Alzheimer's human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer's model mice 96%
- Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19 95%
Similar papers in this journal
- Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome-Alzheimer's disease 97%
- Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation 96%
- Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's disease 94%
Similar papers in this journal
- Leveraging large multi-center cohorts of Alzheimer Disease endophenotypes to understand the role of Klotho heterozygosity on disease risk 98%
- Associations between regional blood-brain barrier disruption, aging, and Alzheimers disease biomarkers in cognitively normal older adults 96%
- Age-related changes in Tau and Autophagy in human brain in the absence of neurodegeneration 95%
Similar papers in this journal
- Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohort 97%
- White matter integrity is associated with cognition and amyloid burden in older adult Koreans along the Alzheimer’s disease continuum 97%
- Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease 97%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.